This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Werner Nickl: Innovator in Pharmaceutical Chemistry
Introduction
Werner Nickl is a notable inventor based in Waldkirch, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Werner Nickl holds a patent for "Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)." This application relates to compounds of a specific formula, which are defined in the specification and claims. The patent outlines methods for preparing these materials, pharmaceutical compositions containing them, and their use in treating ischaemia or reperfusion damage. He has 1 patent to his name.
Career Highlights
Werner Nickl is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on innovative solutions in drug development and therapeutic applications.
Collaborations
Throughout his career, Werner has collaborated with esteemed colleagues, including Barbara Albrecht and Michael Gerisch. These partnerships have contributed to the advancement of research and development in their respective fields.
Conclusion
Werner Nickl's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the treatment of critical health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile